compound semaglutide news Troubling Findings in Study of GLP-1 Compounders Best Peptides for Weight Loss

This sample size provides at least 80% power for the comparison of tirzepatide versus placebo for the change in energy intake during ad libitum test meals (primary outcome) based on a two-sample t -test at an alpha level of 0.05, given an expected treatment difference of 212 kcal and an assumed common standard deviation of 289 kcal for the change in energy intake from baseline

In addition, GLP-1 has been shown to reduce body weight (3, 5, 7), which is favorable for many people with type 2 diabetes

Acta , 1258 , 272-276

Surman is the director of the Clinical and Research Program in Adult ADHD and an associate professor of psychiatry at Harvard Medical School